Bahl & Gaynor Inc. Acquires 4,538 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Bahl & Gaynor Inc. lifted its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 4.5% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 104,853 shares of the company’s stock after acquiring an additional 4,538 shares during the period. Bahl & Gaynor Inc. owned approximately 0.70% of U.S. Physical Therapy worth $11,835,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Vanguard Group Inc. grew its position in U.S. Physical Therapy by 1.7% in the 3rd quarter. Vanguard Group Inc. now owns 1,036,203 shares of the company’s stock worth $95,051,000 after purchasing an additional 17,156 shares in the last quarter. Southernsun Asset Management LLC grew its position in shares of U.S. Physical Therapy by 5.9% during the 4th quarter. Southernsun Asset Management LLC now owns 479,214 shares of the company’s stock valued at $44,634,000 after acquiring an additional 26,758 shares during the period. Norden Group LLC grew its position in shares of U.S. Physical Therapy by 1,841.6% during the 1st quarter. Norden Group LLC now owns 63,938 shares of the company’s stock valued at $7,217,000 after acquiring an additional 60,645 shares during the period. Semanteon Capital Management LP bought a new position in shares of U.S. Physical Therapy during the 4th quarter valued at approximately $767,000. Finally, RK Capital Management LLC bought a new position in shares of U.S. Physical Therapy during the 4th quarter valued at approximately $6,166,000.

Wall Street Analysts Forecast Growth

Separately, Barrington Research reissued an “outperform” rating and set a $122.00 target price on shares of U.S. Physical Therapy in a research report on Thursday, May 9th. One analyst has rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $119.50.

U.S. Physical Therapy Stock Performance

Shares of U.S. Physical Therapy stock traded up $1.60 on Tuesday, reaching $97.68. 33,158 shares of the company traded hands, compared to its average volume of 80,055. The company has a 50 day moving average of $97.18 and a 200 day moving average of $99.95. U.S. Physical Therapy, Inc. has a 52 week low of $78.08 and a 52 week high of $123.82. The company has a debt-to-equity ratio of 0.28, a current ratio of 2.16 and a quick ratio of 2.16. The firm has a market capitalization of $1.47 billion, a PE ratio of 78.11, a PEG ratio of 3.67 and a beta of 1.38.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings data on Tuesday, May 7th. The company reported $0.51 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.58 by ($0.07). U.S. Physical Therapy had a return on equity of 8.03% and a net margin of 4.72%. The firm had revenue of $155.70 million during the quarter, compared to analysts’ expectations of $153.30 million. During the same quarter in the previous year, the company posted $0.59 earnings per share. U.S. Physical Therapy’s revenue for the quarter was up 4.8% compared to the same quarter last year. Equities analysts forecast that U.S. Physical Therapy, Inc. will post 2.84 earnings per share for the current year.

U.S. Physical Therapy Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, June 14th. Stockholders of record on Thursday, May 23rd were issued a $0.44 dividend. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.80%. The ex-dividend date was Wednesday, May 22nd. U.S. Physical Therapy’s payout ratio is currently 143.09%.

Insider Transactions at U.S. Physical Therapy

In other news, insider Eric Joseph Williams sold 2,500 shares of the business’s stock in a transaction dated Friday, May 10th. The stock was sold at an average price of $104.22, for a total value of $260,550.00. Following the completion of the sale, the insider now owns 16,814 shares of the company’s stock, valued at approximately $1,752,355.08. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In other news, insider Eric Joseph Williams sold 2,500 shares of the business’s stock in a transaction dated Friday, May 10th. The stock was sold at an average price of $104.22, for a total value of $260,550.00. Following the completion of the sale, the insider now owns 16,814 shares of the company’s stock, valued at approximately $1,752,355.08. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, COO Graham D. Reeve sold 1,724 shares of the business’s stock in a transaction dated Friday, May 10th. The shares were sold at an average price of $105.46, for a total value of $181,813.04. Following the completion of the sale, the chief operating officer now directly owns 6,970 shares of the company’s stock, valued at approximately $735,056.20. The disclosure for this sale can be found here. In the last three months, insiders sold 10,724 shares of company stock worth $1,114,385. 1.70% of the stock is currently owned by corporate insiders.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.